Academician
ÇİĞDEM PAPİLA
PROFESÖR
İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA CERRAHPAŞA TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
A quick look at recorded outputs — details below.
- Articles 17
- Projects 0
- Books 0
- Proceedings 0
- Patents 0
- Artistic 0
Scopus (SJR)
Q1
4
Q2
8
Q3
3
Q4
1
WoS (JCR)
Q1
4
Q2
4
Q3
6
Q4
1
TR Index
0
articles
Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.
Top 1% articles
0
Top 10% articles
5
Avg percentile
72.1%
Top 1% share
0.0%
Top 10% share
29.4%
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Article list
- 2026 Does Surgical Timing After Neoadjuvant Anti‐HER2 Therapy Affect Pathological Complete Response and Survival in HER2‐Positive Breast Cancer? A Multicenter Retrospective Cohort Study YÖKSİS SJR Q1 JCR Q2 OpenAlex 35.2%
- 2026 Comparative Real‐World Safety Profiles of Fibroblast Growth Factor Receptor Inhibitors: A Pharmacovigilance Study YÖKSİS SJR Q2 JCR Q3 OpenAlex 64.8%
- 2026 Long-term outcomes of rare pure histological subtypes of breast cancer in a tertiary single-center retrospective cohort YÖKSİS SJR Q2 JCR Q3 OpenAlex 57.6%
- 2026 Does the CRP/Albumin Ratio Independently Predict Survival in Metastatic Colorectal Cancer? Insights from a Propensity Score-Matched Cohort YÖKSİS OpenAlex 75.9%
- 2026 Diagnostic utility and discriminative ability of cholesterol-modified prognostic nutritional index and inflammatory indicators in colorectal cancer: a retrospective case-control study YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 91.5%
- 2026 Prognostic value of nutritional and inflammation-based scores in advanced soft tissue sarcoma treated with trabectedin: a multicenter study YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 93.6%
- 2026 Hemophagocytic Lymphohistiocytosis Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of Spontaneous Reports YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 98.5%
- 2025 Is Body Mass Index a Prognostic Factor in Metastatic HER2-Positive Breast Cancer? A Real-World Multicenter Study YÖKSİS SJR Q4 OpenAlex 65.5%
- 2025 Inflammatory and Nutritional Markers Predicting Pathological Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Multicenter Real-World Study YÖKSİS SJR Q2 JCR Q1 OpenAlex top 10% OpenAlex 93.2%
- 2025 Low Skeletal Muscle Index as a Predictor of Pathological Complete Response in HER-2 Positive and Triple-Negative Breast Cancer YÖKSİS SJR Q2 JCR Q1 OpenAlex 78.9%
- 2024 Obesity Is an Independent Prognostic Factor That Reduced Pathological Complete Response in Operable Breast Cancer Patients YÖKSİS SJR Q2 JCR Q1 OpenAlex 84.5%
- 2021 Association between Bone Mineral Density and Bone Turnover Markers in Breast Cancer Patients and Bone-Only Metastasis YÖKSİS SJR Q2 JCR Q3 OpenAlex 59.2%
- 2021 Circulating nuclear factor-kappa B mediates cancer-associated inflammation in human breast and colon cancer YÖKSİS SJR Q3 JCR Q4 OpenAlex 66.9%
- 2021 The evaluation of oxidative stress parameters in breast and colon cancer YÖKSİS SJR Q3 JCR Q3 OpenAlex top 10% OpenAlex 93.1%
- 2021 The clinical significance of preoperative plasma fibrinogen levels and platelet counts in resectable colon cancer YÖKSİS SJR Q1 JCR Q2 OpenAlex 88.1%
- 2021 The Effect of Menstrual Cycle Phase on the Prognostic Factors in Patients with Premenopausal Breast Tumors YÖKSİS SJR Q3 JCR Q3 OpenAlex 32.3%
- 2020 <p>Associations Between miRNAs and Two Different Cancers: Breast and Colon</p> YÖKSİS SJR Q2 JCR Q3 OpenAlex 47.0%